Yildiz, M.
(2026).
 Long-acting injectable antipsychotics for schizophrenia treatment: optimal duration from a cost-effectiveness standpoint.
<em>Medical Research Archives, 14</em>(3).
doi:10.18103/mra.v14i3.7354